Alphina Therapeutics
PrivateLast Round
Seed Round
Mar 16, 2026
Total Funding Raised
$40M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Alphina Therapeutics is a biotechnology company developing small molecule inhibitors of NAMPT to treat a variety of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alphina Therapeutics Comparables
Compare Alphina Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Remedy Plan Therapeutics | 87% | |
| OncoTartis, Inc. | 81% | |
| Tessellate BIO | 76% | |
Alphina Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 16, 2026 | ||||
| Series A | Sep 1, 2021 | ||||
| Pre Seed | Dec 15, 2020 |
Key People
Founding team and executive leadership
Alphina Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Series A, Pre Seed |
| HighCape Capital | Series A, Pre Seed |
| Osage University Partners | Series A |
| Canaan Partners | Series A |
| Alexandria Venture Investments | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 48% month-over-month.
Alphina Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alphina Therapeutics's valuation, stock price, and market status.